BNTC - Benitec Corp Kompaniya qiymatining foyda o‘sish sur’atiga nisbati
Benitec Biopharma Inc. (BNTC) genlarni jimjitish usullarini ishlab chiqish bilan birga, investitsiyalar va biofarmatsevtika grantlari orqali daromad keltiradi. PEG koeffitsiyenti tendentsiyasi aktivning bozor qiymatini aks ettiradi, bunda 0.00 parametrning joriy holatini ifodalaydi. Bu dasturiy ta'minotni tekshirish strategiyasi va mushak distrofiyasi dori vositasi uchun o'tkazilayotgan klinik sinovlar bilan bog'liqdir. Biotehnologiya sektorining o'ziga xos tabiati kompaniyani makroshoklarga chidamli va YaIM sikllaridan mustaqil qiladi.
Benitec Biopharma Inc. (BNTC) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi haqida ma'lumot:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Benitec Biopharma Inc.|BNTC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati benitec.com|BNTC - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Benitec|BNTC - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Benitec Biopharma|Kritik likvidlik koeffitsiyenti benitec.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
BNTC - Sof foyda|Kutilayotgan sof daromad Benitec Biopharma Inc.|BNTC - P/E multiplikatori|Forvard P/E multiplikatori Benitec Corp|BNTC - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Benitec|BNTC - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Benitec Biopharma|BNTC - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi benitec.com|BNTC - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Benitec Biopharma Inc.
Kompaniyaning umumiy tahlili:BNTC, Benitec Biopharma Inc
Benitec Biopharma Inc. (BNTC) kompaniyasida genlarni jimjitish laboratoriyalarining maksimal quvvatdan foydalanilishi va ishlab chiqarishning autsorsingga berilishi foydani kengaytirish uchun asos yaratadi, bu esa PEG koeffitsiyentini biznes samaradorligini baholashning asosiy vositasiga aylantiradi. Ushbu koeffitsient joriy P/E koeffitsiyentini operatsion daromadning o'sish sur'ati bilan solishtiradi: birdan past qiymat aktivning qadrini past baholaganini anglatadi, bu esa investorlarga aksiyalar narxining keskin oshish potentsialini aniqlash imkonini beradi.
Benitec Biopharma Inc. raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Tempus AI, Inc|Qiagen Group - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IONS (Isis Pharmaceuticals)|Repligen Corporation - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aviditybiosciences.com|CRSP: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori GeneDx Holdings|Narx-foyda va o‘sish multiplikatori RARE|BEAM: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SRPT|Narxning foydaga va o‘sish sur’atiga nisbati TWST (twistbioscience.com)|PEG multiplikatori TXG (10x Genomics)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Intellia Therapeutics Inc (NTLA)|STOK - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda BioLife|Wave Life Sciences (WVE) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati MAZE (mazetx.com)|SION (Sionna Therapeutics) - PEG multiplikatori|PRME: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori TSHA|PEG multiplikatori uniQure Pharma (QURE)|Narxning foydaga va o‘sish sur’atiga nisbati MeiraGTx Holdings plc MGTX|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RGNX|SLDB - Narxning foydaga va o‘sish sur’atiga nisbati|Ocugen Inc (OCGN) - Narx-foyda va o‘sish multiplikatori|PACB: PEG multiplikatori|Design Corp (DSGN) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori RCKT|FDMT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori LXEO|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati korrobio.com|Narxning foydaga va o‘sish sur’atiga nisbati Editas EDIT|SLN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ProQR Therapeutics NV - PEG multiplikatori|Codexis, Inc. (CDXS) - Narx-foyda va o‘sish multiplikatori|SGMO (Sangamo Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|NAUT - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|MGX (Metagenomi, Inc) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati DTIL|Narxning foydaga va o‘sish sur’atiga nisbati Generation Bio Co. (GBIO)|boundlessbio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Exicure - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IMNN (Imunon Inc)|RXi Pharmaceuticals - PEG multiplikatori|Mustang Bio, Inc. (MBIO) - Narx-foyda va o‘sish multiplikatori|RNAZ: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BNGO|Narxning foydaga va o‘sish sur’atiga nisbati Applied DNA Sciences, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BLUE (bluebird bio Inc.)|PEG multiplikatori IPA|PEG multiplikatori Omega Therapeutics Corp (OMGA)|PEG multiplikatori OMIC (Singular Genomics Systems)|regulusrx.com - Narxning foydaga va o‘sish sur’atiga nisbati|Syros Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Telesis Bio Inc.|TRACON (TCON) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti UBX
